About the Metastatic Uveal Melanoma Session
Metastatic Uveal Melanoma poses a significant challenge in cancer research due to its aggressive nature and limited treatment options. This rare form of eye cancer often spreads to the liver, where it becomes especially difficult to treat. Researchers are exploring various approaches, including targeted therapies and immunotherapies, to improve outcomes for patients. Recent advancements in understanding the molecular mechanisms driving uveal melanoma metastasis offer hope for developing more effective treatments. Additionally, ongoing clinical trials are investigating novel treatment combinations and precision medicine strategies tailored to individual patients' genetic profiles. Despite the challenges, the dedication of researchers and clinicians continues to drive progress towards finding better therapies and ultimately improving survival rates for patients with metastatic uveal melanoma.
Topics Covered in Metastatic Uveal Melanoma
Hepatic Tropism
Surveillance Imaging
Liver-Directed Therapy
T-Cell Redirecting Therapy
Checkpoint Combinations
GNAQ Signaling
Related Scientific Sessions at CIOC 2027
Why Attend the Metastatic Uveal Melanoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Metastatic Uveal Melanoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Metastatic Uveal Melanoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Metastatic Uveal Melanoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Metastatic Uveal Melanoma Conference 2027 — FAQs
What is the Metastatic Uveal Melanoma track at CIOC 2027?
The Metastatic Uveal Melanoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Metastatic Uveal Melanoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Metastatic Uveal Melanoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Metastatic Uveal Melanoma are all welcome — whether presenting or attending.
Can I present my research in the Metastatic Uveal Melanoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Metastatic Uveal Melanoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Metastatic Uveal Melanoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.